Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Mayo Clinic
Eli Lilly and Company
Terremoto Biosciences Inc.
Bristol-Myers Squibb
AstraZeneca
Radiopharm Theranostics, Ltd
Ocellaris Pharma, Inc.
Tanabe Pharma America, Inc.
LigaChem Biosciences, Inc.
Incyte Corporation
Cancer Research UK
ModeX Therapeutics, An OPKO Health Company
Klus Pharma Inc.
RAPT Therapeutics, Inc.
UNICANCER
Aminex Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Cancer Research UK
Second Affiliated Hospital of Guangzhou Medical University
Innolake Biopharm
GeneMedicine Co., Ltd.
Klus Pharma Inc.
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Gilead Sciences
NKGen Biotech, Inc.
National Institutes of Health Clinical Center (CC)
University of Plymouth